Thought Leader Select Supports Top Biopharma with KOL Strategies in Head and Neck Cancer

July 1, 2014 · Leave a comment

July 1, 2014 (CHAPEL HILL, NC) Thought Leader Select, a research and consulting firm serving the life sciences industries, has initiated new research and consulting work in support of a top global biopharmaceutical company’s developing portfolio of treatments for head and neck cancer.

The firm’s latest engagement in support of the collaborative work among life sciences companies and leaders in the medical community consists of detailed research and engagement planning for work with experts at Canadian centers of excellence in head and neck cancer. The client company, known worldwide as a leader in the development of prescription medicines, has engaged Thought Leader Select for more support in multiple therapeutic areas and disease states, including key opinion leader and centers of excellence identification and profiling in multiple cancers, diabetes, and infectious diseases.

According to the National Cancer Institute at the National Institutes of Health, head and neck cancers originate in the squamous cells that line the moist areas of the head and neck.  Alcohol and tobacco use, as well as exposure to human papilloma virus, are important risk factors related to the development of many incidences of head and neck cancer.  Physicians diagnose nearly half a million new cases of head and neck cancers worldwide each year.

Thought Leader Select, headquartered ... read more »


Thought Leader Select Announces Hiring of Carol Younkin

February 4, 2014 · Leave a comment

February 4, 2014 (CHAPEL HILL, NC) Thought Leader Select, a research and consulting firm serving the life sciences industries of pharmaceuticals, biotechnology, medical devices, and diagnostics, announces the hiring of Carol Younkin to a leadership position in its in-house research group.

Younkin takes on the research manager role at Thought Leader Select after nearly two decades serving pharmaceutical giant Eli Lilly in a variety of capacities, most recently as a medical science liaison supporting the company’s diabetes and growth disorders portfolios. In other roles at Lilly, Younkin managed company relationships with over 100 national and global thought leaders in endocrinology, provided training and consultation to Lilly’s endocrine medical science liaison teams, and developed internal systems for identifying, profiling, and engaging leading medical experts to assist the company in the development of its portfolio of treatments for diabetes.

In her new role at Thought Leader Select, Younkin will lead efforts to identify key opinion leaders and centers of excellence to meet life sciences industry client directives in multiple therapeutic areas and diseases.

Younkin earned a doctorate in health sciences from A.T. Still University and a master’s in health education from Kent State University, where she also earned her bachelor’s degree in nursing.  Her post-graduate studies focused ... read more »


Thought Leader Select Sponsors Successful Global MSL Society Event in Paris

November 8, 2013 · Leave a comment

The MSL Society is celebrating the success of its second successful global event of the year, the Paris 2013 Conference.   Thought Leader Select, a founding sponsor of the MSL Society, also sponsored the Paris event.

Held at the Hyatt Regency Paris Etoile, the action-packed conference brought together medical science liaisons and medical affairs professionals from nearly every corner of the globe and multiple life science industries, including pharmaceuticals, biotechnology, medical devices and diagnostics, and clinical research organizations.

The event opened in customary MSL Society fashion, with a networking reception for the conference participants to get to know each other in a comfortable setting on the evening of October 28.  During the following two days of intense content-sharing, participants heard a range of experienced speakers deliver critical information on a broad-ranging set of topics that impact the daily professional lives of MSLs and the departments and companies they serve.  Topics discussed included the Evolving Role of the MSL, Building a Medical Affairs Department, MSL Training, and Building an MSL Team Structure in a Therapeutic Area.

Speakers at the event included several leading lights in the global medical affairs community, including Elizabeth Kupferer of Sequenom (USA), Martin Obladen of Bayer Healthcare (Germany), Jennifer Williams of Bard Medical (USA), Ayse Olmez of ... read more »


Lilly, Biopharmaceutical Companies Impact Patient Care with Medical Professionals

May 29, 2013 · Leave a comment

We were inspired by a recent PharmaLive story on Lilly’s new initiative highlighting the key work that medical professionals undertake at the company during all facets and phases of drug discovery and development.

The story notes that over 500 physicians, 700 pharmacists, and 1400 medical research scientists work at Lilly, and the company is touting their work with the medical community to bring new treatments to market, all while keeping patient needs first.

While many are either skeptical or unaware of these interactions, the article speaks to why we are in the business of what we do at Thought Leader Select—delivering key information to pharmaceutical, biotechnology, and medical device companies so that external relations officials at companies like Lilly can optimize their medical community interactions in the service of patients.

Companies in life science disciplines utilize key opinion leaders in medicine in a host of ways to ensure that new treatments target unmet medical needs and have the best impact possible on patient outcomes.  Their collaborative work results in clinical research, patient advocacy, bioethics, regulatory compliance, and medical education, all key drivers in medicine today.

Thought Leader Select is proud that our work in identifying and profiling the right key opinion leaders and medical centers of excellence to collaborate with industry in these many contexts and more optimizes these industry/medical community relationships for ... read more »


Thoughts on the MSL Society’s Inaugural Conference

April 17, 2013 · Leave a comment

Industry Insights from Paul Meade, M.Sc, MPH

Allison Murphy and I had the pleasure of participating in the MSL Society’s inaugural global conference and gala in Philadelphia earlier this month.  At Thought Leader Select, we always enjoy the opportunity to meet some of our great colleagues in medical affairs in the pharmaceutical, biotechnology, and device industries, but this event proved to be really special.

Since joining our company last year, Allison has continued to make a real impact in the medical affairs community.  After serving much of the last decade in Eli Lilly’s medical affairs division in support of the company’s endocrinology portfolio, Allison has brought a wealth of medical affairs expertise to Thought Leader Select. This expertise has continued to evolve, even as a consultant, through her membership and advisory board participation with the MSL Society, a dynamic group that we are proud to support as a company.

Dr. Samuel Dyer, the founder and head of the MSL Society, approached us a few months ago, asking for help with the burgeoning organization’s first global event.  As a veteran of the industry myself, I have participated in many events through the years, as a participant, speaker, and sponsor. I must admit that I was more than a little skeptical about another conference/event series emerging in a space with ... read more »


MSL Society Announces Inaugural Global Conference and Gala

February 7, 2013 · Leave a comment

For Immediate Release

February 7, 2013 (Chapel Hill, NC) The Medical Science Liaison Society (MSL Society) is planning its first global conference and gala for April 2013.

The event will take place at Philadelphia’s Hyatt at the Broadview on South Broad Street, from April 1-3.  The 2013 MSL Society Conference and Gala is the first event of its kind, a tangible extension of the non-profit organization’s mission to bring together global medical affairs professionals for education and networking in an effort to support the profession.

Attendees will include Medical Affairs and MSL Leadership, as well as other professionals focusing on key topic including KOL access, HEOR, clinical trials, clinical investigation, key opinion leader relationship management, and medical communications.  The emerging roster of speakers includes luminaries from the world of medical affairs, including Dr. Stewart Rosen, Vice President of Medical Affairs at Quintiles, Dr. Robert Ang, Vice President of Medical Affairs at Cadence Pharmaceuticals, and Dr. Elizabeth Kupferer, Director of Medical Affairs at Sequenom.  

Highlights of the three-day event include a welcome reception on day one, followed by a full day of education and networking, the gala dinner to culminate day two, and a final round of education and networking on day three.

“We’ve planned our first live conference with the needs ... read more »


Canadian Pharma Chooses Thought Leader Select for COPD Key Opinion Leader Engagement Strategy

December 20, 2012 · Leave a comment

December 20, 2012 (CHAPEL HILL, NC) Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a medical strategy engagement in pulmonology with a top Canadian biopharmaceutical company.

The company, part of a select group of global leaders in drug development for products treating chronic obstructive pulmonary disorder (COPD), approached Thought Leader Select for support with scientific advisory boards and continuing health education (CHE) initiatives across multiple Canadian provinces.  Having already worked with Thought Leader Select to form rosters of key opinion leaders in Canadian rheumatology and oncology circles, the company will formulate its panel of key experts in pulmonology by deploying Thought Leader Select’s team to assess the skills and experiences of physician specialists across the country.

Known for the versatility of applications for its in-house research, Thought Leader Select’s research group will analyze the skills and experience of these leading experts in multiple areas where they collaborate to advance the science of medicine and patient care, including basic and clinical research, scientific journal publishing, treatment guidelines, and more.

Throughout the remainder of the engagement, Thought Leader Select’s consulting team will provide strategic guidance, tactical recommendations for strengthening key opinion leader relationships in the nursing and pharmacy communities, and a suite of tools to promote collaborative work with KOLs.  Among these ... read more »


Thought Leader Select’s Murphy Named to MSLS Advisory Committee

November 15, 2012 · Leave a comment

The Medical Science Liaison Society, a non-profit focused on advancing the Medical Science Liaison career in the pharmaceutical, biotechnology, and medical device industries, has named Thought Leader Select’s Allison Murphy to its global advisory committee.

The MSL Society, led by Dr. Samuel Dyer from its Florida headquarters, is bringing the global MSL community together through a variety of educational and networking platforms, including webinars, white papers, conferences, and multiple social media outlets.  Dr. Dyer and the MSL Society team of advisors are collaborating with several premier industry partners, including First Word Reports and EyeforPharma.

Prior to joining Thought Leader Select as a global sales consultant in 2012, Murphy spent the previous decade of her career working as a Medical Science Liaison at Eli Lilly and Company in the therapeutic area of Endocrinology.  Murphy collaborated with multiple Key Opinion Leaders to drive Lilly’s medical initiatives in support of products aimed at treating conditions ranging from diabetes to growth disorders.

“I am very proud to be a part of the MSL Society’s global advisory committee,” stated Murphy.  “I know first-hand from my days at Lilly that there weren’t enough of the right resources and networking opportunities for MSLs and Medical Affairs executives, to help them advance their careers and ... read more »


The Necessity of Quality Measures When Profiling Thought Leaders in Medicine

October 23, 2012 · Leave a comment

Industry Insights from Paul Meade, M.Sc., MPH

There are several companies that claim to identify and profile key opinion leaders in healthcare, and they using an array of methodologies and techniques to arrive at defining the practitioners who drive a given therapeutic area or disease state. And yet, while all claim to have built a better mousetrap for profiling these thought leaders, what is sadly lacking among many these vendors is quality control and good quality measures.

Notwithstanding the variety of definitions of a key opinion leader emblematic of the lack of standardization across the industry, there is also a wide variation in the quality of the output from one vendor to the next. For instance, some companies utilize automated web-crawlers (think: glorified Google Alerts) to mine public information—for the most part, scientific publications data, and simply foist upon their clients a “data dump.” The content of these data dumps is often completely devoid of sound quality control—for example, it is not uncommon for an IT-based vendor to offer up John Smith, John D. Smith, and JD Smith as three separate KOLs, when, in reality, Dr. John D. Smith is a true one-of-a-kind. Likewise, we have also seen lists where vendors may conflate Dr. David Lee from Sacramento with Dr. David Lee from Shanghai, when human researchers would see these to ... read more »


Top US Pharma Chooses Thought Leader Select for Obesity Centers of Excellence Initiative

October 18, 2012 · Leave a comment

October 18, 2012 (CHAPEL HILL, NC)  Thought Leader Select, a Chapel Hill, NC-based consulting firm serving the biopharmaceutical, medical device, and diagnostics industries, announces the commencement of a national engagement focused on medical centers of excellence in obesity with a top U. S. biopharmaceutical company.

The company, part of a select group of global leaders in drug development for products treating the condition of obesity, approached Thought Leader Select for support with a variety of collaborative efforts, including medical science liaison outreach to leading universities, medical schools, teaching hospitals, and specialty clinics in this area.  Having already worked with Thought Leader Select to form rosters of key opinion leaders in endocrinology, primary care, nursing, pharmacy, and long-term care in the treatment of type I and type II diabetes and obesity, the company has now chosen Thought Leader Select to pinpoint the leading centers of excellence in the treatment of obesity in the United States.

Known for the versatility of applications for its in-house research and analysis, Thought Leader Select’s research group will assess the skills and experience of selected centers, detailing the collaborative activities of leading physicians and other health care professionals, including registered nurses, physician assistants, nurse practitioners, clinical pharmacists, and medical researchers, the people who advance the science of medicine and patient care, through basic and clinical research, scientific journal ... read more »


Older posts »